PubMed:32264791 / 694-977
Annnotations
LitCovid-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7984 | 56-64 | SP_10 | denotes | SARS-CoV |
| T7985 | 97-107 | SP_7 | denotes | SARS-CoV-2 |
| T7986 | 200-205 | SP_6;PG_10 | denotes | human |
| T7987 | 206-210 | PG_10 | denotes | ACE2 |
| T7988 | 255-268 | BV_19 | denotes | pathogenicity |
| T7989 | 272-282 | SP_7 | denotes | SARS-CoV-2 |
LitCovid_AGAC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| p125237s33 | 174-181 | Interaction | denotes | binding |
| p125237s34 | 182-190 | Interaction | denotes | affinity |
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 0-283 | Sentence | denotes | Although sharing a close evolutionary relationship with SARS-CoV, the receptor-binding domain of SARS-CoV-2 differs in several key amino acid residues, allowing for stronger binding affinity with the human ACE2 receptor, which may account for the greater pathogenicity of SARS-CoV-2. |
| T5 | 0-283 | Sentence | denotes | Although sharing a close evolutionary relationship with SARS-CoV, the receptor-binding domain of SARS-CoV-2 differs in several key amino acid residues, allowing for stronger binding affinity with the human ACE2 receptor, which may account for the greater pathogenicity of SARS-CoV-2. |
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 0-283 | DRI_Background | denotes | Although sharing a close evolutionary relationship with SARS-CoV, the receptor-binding domain of SARS-CoV-2 differs in several key amino acid residues, allowing for stronger binding affinity with the human ACE2 receptor, which may account for the greater pathogenicity of SARS-CoV-2. |